Swiss Pharma Giant Novartis Expects China To Be Its Second Biggest Market By 2024

Swiss pharma giant Novartis expects China to be its second biggest market by 2024

China International Import Expo

Novartis: The making of a pharma giant

SWI swissinfo.ch - English

GLOBALink | Swiss pharma giant Novartis expects China to be its second biggest market by 2024

CEO of Swiss drugmaker Novartis outlines some major industry trends for 2024

CNBC International News

Novartis profit tops expectations

Novartis and GSK swap assets in pharma industry reshape - economy

Novartis CEO: Expect continued growth in 2023

CNBC International News

Novartis sees healthy drug market

South China Morning Post

Medical care giant has big plans with Healthy China 2030

International Channel Shanghai

Gravitas | Medical marvel: China's new cure for diabetes

WION

Five Reasons Chinese Pharma Expects More Investment

The Wall Street Journal

Novartis CEO on the impact of the U.S. election for pharma

CNBC International News

Novartis generated $40 billion in innovative medicine sales, says CEO

CNBC Television

Unlocking the Future: How MNCs Can Tap Into China’s Booming Pharma Market

China's Biggest Pharma Scandal | The Kangmei Pharmaceutical Fraud

Top 5 Pharmaceutical companies in world. #top5 #pfizer #novartis #pharmacompanies #vrialshort

Dr. Kate Tulenko on 'Big Pharma' in China

“Big market opportunity...” India's pharma giant eyes Chinese market

[Industry Voice #15] Pharma Entering New Markets | Sanofi, Novartis, Pfizer Cases

OCT Clinical Trials

Novartis boss keeps faith in new cancer treatments

SWI swissinfo.ch - English